China COVID-19 Vaccine on trial

China reached an important new level of vaccine development with the start of the phase three clinical trial of an inactivated vaccine against COVID-19. It is the first vaccine to reach a late-stage, mass scale human trial,

 The Institute of Microbiology of the Chinese Academy of Sciences said in a statement that Chinese authorities approved the phase one trial of the nation’s first  protein vaccine against COVID-19.

Comments

Popular posts from this blog

Farewell Sermon of Prophet Muhammad (PBUH)

Maldives : One of the best tourist destination